NASDAQ : KZIA
Kazia Therapeutics Limited — Financial statements
Healthcare · Biotechnology · Australia
Last price 8.5 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 116.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Kazia Therapeutics Limited (KZIA) reported revenue of 1.90M AUD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 42.00K | 42.00K | 2.31M | 15.18M | ||
| Other Revenue | 1.86M | 1.79M | 173.00K | 1.00K | 10.00K | |
| Revenue | 1.90M | 1.83M | 2.48M | 1.00K | 10.00K | 15.18M |
| Gross Profit | 1.90M | 1.83M | 2.48M | 1.00K | 10.00K | 15.18M |
| Selling, General & Admin | 12.17M | 8.72M | 13.56M | 8.58M | 5.24M | 7.02M |
| Research & Development | 8.04M | 7.33M | 17.38M | 15.56M | 20.17M | 14.54M |
| Other Operating Expenses | -15.00K | -2.19K | ||||
| Operating Expenses | 20.21M | 16.05M | 30.94M | 24.15M | 25.39M | 21.56M |
| Operating Income | -18.31M | -14.22M | -28.46M | -24.15M | -25.38M | -6.38M |
| Interest & Investment Income | 204.26K | 72.00K | 12.00K | 22.00K | 2.00K | 42.24K |
| Other Non Operating Income (Expenses) | 266.57K | -2.48M | 1.28M | |||
| EBT Excluding Unusual Items | -17.84M | -16.62M | -27.17M | -24.12M | -25.38M | -6.34M |
| Asset Writedown | -13.38M | -13.38M | ||||
| Other Unusual Items | 6.80M | 7.55M | 119.00K | 3.39M | -2.57M | |
| Pretax Income | -24.41M | -22.45M | -27.05M | -20.74M | -25.38M | -8.91M |
| Income Tax Expense | -1.61M | -1.75M | -271.00K | -271.00K | -368.00K | -484.35K |
| Earnings From Continuing Operations | -22.80M | -20.70M | -26.78M | -20.46M | -25.01M | -8.42M |
| Net Income | -22.80M | -20.70M | -26.78M | -20.46M | -25.01M | -8.42M |
| Net Income to Common | -22.80M | -20.70M | -26.78M | -20.46M | -25.01M | -8.42M |
| Shares Outstanding (Basic) | 2.23M | 1.10M | 527.35K | 368.57K | 264.94K | 235.35K |
| Shares Outstanding (Diluted) | 2.23M | 1.10M | 527.35K | 368.57K | 264.94K | 235.35K |
| EPS (Basic) | -10.22 | -18.89 | -50.78 | -55.53 | -94.42 | -35.78 |
| EPS (Diluted) | -10.22 | -18.89 | -50.78 | -55.53 | -94.42 | -35.80 |
| Free Cash Flow | -14.40M | -13.28M | -9.58M | -15.16M | -22.76M | -9.11M |
| Free Cash Flow Per Share | -6.45 | -12.12 | -18.17 | -41.12 | -85.92 | -38.71 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -964.22% | -777.31% | -1,147.20% | -2,414,600.00% | -253,840.00% | -42.01% |
| Profit Margin | -1,200.90% | -1,131.88% | -1,079.32% | -2,046,500.00% | -250,140.00% | -55.47% |
| Free Cash Flow Margin | -758.36% | -725.97% | -386.17% | -1,515,600.00% | -227,620.00% | -60.01% |
| EBITDA | -17.84M | -13.28M | -26.59M | -22.28M | -23.52M | -5.11M |
| EBITDA Margin | -33.68% | |||||
| D&A For EBITDA | 466.29K | 934.00K | 1.87M | 1.87M | 1.87M | 1.27M |
| EBIT | -18.31M | -14.22M | -28.46M | -24.15M | -25.38M | -6.38M |
| EBIT Margin | -42.01% |
Balance sheet
Fiscal year July - June; amounts in AUD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 69.46M | 4.34M | 1.66M | 5.24M | 7.36M | 27.59M |
| Cash & Short-Term Investments | 69.46M | 4.34M | 1.66M | 5.24M | 7.36M | 27.59M |
| Accounts Receivable | 1.00K | |||||
| Other Receivables | 307.85K | 90.00K | 133.00K | 104.00K | 51.35K | 76.67K |
| Receivables | 307.85K | 90.00K | 133.00K | 105.00K | 51.35K | 76.67K |
| Prepaid Expenses | 210.50K | 491.00K | 591.00K | 1.63M | 2.00M | 1.72M |
| Other Current Assets | 7.69K | 8.00K | 3.76M | 3.79M | 39.62K | 7.69K |
| Total Current Assets | 69.99M | 4.93M | 6.14M | 10.77M | 9.45M | 29.39M |
| Other Intangible Assets | 1.09M | 1.09M | 15.40M | 17.27M | 19.14M | 22.00M |
| Other Long-Term Assets | 40.00K | 40.00K | 40.00K | 43.00K | 7.30M | 6.69M |
| Total Assets | 71.11M | 6.06M | 21.59M | 28.08M | 35.89M | 58.09M |
| Accounts Payable | 6.13M | 5.64M | 4.55M | 857.00K | 1.52M | 1.89M |
| Accrued Expenses | 3.97M | 4.86M | 10.88M | 4.16M | 2.60M | 3.27M |
| Short-Term Debt | 98.81K | 396.00K | 634.00K | 1.80M | 1.84M | |
| Other Current Liabilities | 14.18M | 3.15M | 9.73M | 750.00K | 758.84K | 3.16M |
| Total Current Liabilities | 24.37M | 14.05M | 25.80M | 7.57M | 6.73M | 8.33M |
| Pension & Post-Retirement Benefits | 537.00 | 37.00K | 35.00K | 59.00K | 116.60K | 54.68K |
| Long-Term Deferred Tax Liabilities | 271.63K | 272.00K | 2.02M | 2.29M | 2.56M | 2.93M |
| Other Long-Term Liabilities | 3.75M | 6.12M | 8.21M | 8.93M | ||
| Total Liabilities | 24.65M | 14.36M | 31.60M | 16.03M | 17.61M | 20.24M |
| Common Stock | 186.59M | 123.05M | 101.64M | 97.45M | 84.48M | 80.29M |
| Retained Earnings | -145.61M | -134.83M | -115.13M | -89.08M | -68.62M | -44.20M |
| Comprehensive Income & Other | 5.48M | 3.48M | 3.48M | 3.68M | 2.41M | 1.76M |
| Total Common Equity | 46.47M | -8.30M | -10.02M | 12.05M | 18.27M | 37.85M |
| Shareholders' Equity | 46.47M | -8.30M | -10.02M | 12.05M | 18.27M | 37.85M |
| Total Liabilities & Equity | 71.11M | 6.06M | 21.59M | 28.08M | 35.89M | 58.09M |
| Total Debt | 98.81K | 396.00K | 634.00K | 1.80M | 1.84M | |
| Net Cash (Debt) | 69.36M | 3.95M | 1.02M | 3.44M | 5.52M | 27.59M |
| Net Cash Per Share | 31.09 | 3.60 | 1.94 | 9.35 | 20.84 | 117.22 |
| Filing Date Shares Outstanding | 11.34M | 1.83M | 870.99K | 472.70K | 299.27K | 264.02K |
| Total Common Shares Outstanding | 11.34M | 1.62M | 665.70K | 456.06K | 277.51K | 264.02K |
| Working Capital | 45.61M | -9.12M | -19.65M | 3.21M | 2.72M | 21.06M |
| Book Value Per Share | 4.10 | -5.13 | -15.05 | 26.42 | 65.85 | 143.36 |
| Tangible Book Value | 45.38M | -9.39M | -25.42M | -5.22M | -864.37K | 15.85M |
| Tangible Book Value Per Share | 4.00 | -5.80 | -38.18 | -11.44 | -3.11 | 60.03 |
Cash flow statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -22.80M | -20.70M | -26.78M | -20.46M | -25.01M | -8.42M |
| Depreciation & Amortization | -711.00 | 934.00K | 1.87M | 1.87M | 1.87M | 1.27M |
| Asset Writedown & Restructuring Costs | 13.38M | 13.38M | ||||
| Loss (Gain) From Sale of Investments | -25.00K | |||||
| Stock-Based Compensation | 4.82M | 653.00K | 533.00K | 1.16M | 1.68M | 636.38K |
| Other Operating Activities | -7.18M | -4.53M | 4.82M | -2.05M | -2.15M | 3.00M |
| Change in Accounts Receivable | 3.54M | 3.80M | 5.00K | 3.45M | -7.00K | -5.03M |
| Change in Accounts Payable | -4.57M | -4.95M | 10.74M | 569.00K | -528.00K | 1.01M |
| Change in Other Net Operating Assets | 25.35K | -111.00K | -470.00K | 584.00K | 1.76M | -1.09M |
| Operating Cash Flow | -14.40M | -13.28M | -9.58M | -15.16M | -22.76M | -9.11M |
| Other Investing Activities | -2.37M | |||||
| Investing Cash Flow | -2.37M | |||||
| Short-Term Debt Issued | 776.00K | |||||
| Total Debt Issued | 776.00K | |||||
| Short-Term Debt Repaid | -371.00K | |||||
| Total Debt Repaid | -371.00K | |||||
| Net Debt Issued (Repaid) | 405.00K | |||||
| Issuance of Common Stock | 60.54M | 13.66M | 5.96M | 13.37M | 4.22M | 29.78M |
| Other Financing Activities | 21.03M | 2.32M | -376.57K | -400.75K | -492.74K | -1.67M |
| Financing Cash Flow | 81.56M | 15.98M | 5.99M | 12.97M | 3.73M | 28.11M |
| Foreign Exchange Rate Adjustments | -768.88K | -16.00K | 12.00K | 64.00K | 1.18M | -175.62K |
| Net Cash Flow | 66.40M | 2.69M | -3.58M | -2.12M | -20.23M | 18.82M |
| Free Cash Flow | -14.40M | -13.28M | -9.58M | -15.16M | -22.76M | -9.11M |
| Free Cash Flow Margin | -758.36% | -725.97% | -386.17% | -1,515,600.00% | -227,620.00% | -60.01% |
| Free Cash Flow Per Share | -6.45 | -12.12 | -18.17 | -41.12 | -85.92 | -38.71 |
| Levered Free Cash Flow | 1.10M | -14.91M | 5.05M | -14.62M | -16.04M | 1.26M |
| Unlevered Free Cash Flow | 1.10M | -14.91M | 5.05M | -14.62M | -16.04M | 1.26M |
| Change in Working Capital | -2.61M | -3.01M | 10.00M | 4.33M | 862.00K | -5.59M |
Ratios
Fiscal year July - June; amounts in AUD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 110.31M | 7.01M | 6.81M | 26.45M | 58.28M | 127.81M |
| Enterprise Value | 64.05M | 5.20M | 4.63M | 23.84M | 47.23M | 112.86M |
| Last Close Price | 8.50 | 6.27 | 11.43 | 58.00 | 210.00 | 493.00 |
| PS Ratio | 91.98 | 5.84 | 4.11 | 39,743.17 | 8,458.34 | 11.23 |
| PB Ratio | 3.11 | -1.29 | -1.02 | 3.30 | 4.63 | 4.50 |
| P/TBV Ratio | 3.85 | 10.76 | ||||
| EV/Sales Ratio | 55.44 | 4.34 | 2.79 | 35,823.57 | 6,855.40 | 9.91 |
| Debt / Equity Ratio | 0.00 | -0.05 | -0.06 | 0.15 | 0.10 | |
| Net Debt / Equity Ratio | -1.49 | 0.48 | 0.10 | -0.29 | -0.30 | -0.73 |
| Net Debt / EBITDA Ratio | 3.89 | 0.30 | 0.04 | 0.15 | 0.23 | 5.39 |
| Net Debt / FCF Ratio | 4.82 | 0.30 | 0.11 | 0.23 | 0.24 | 3.03 |
| Asset Turnover | 0.04 | 0.13 | 0.10 | 0.00 | 0.00 | 0.37 |
| Quick Ratio | 2.86 | 0.32 | 0.07 | 0.71 | 1.10 | 3.32 |
| Current Ratio | 2.87 | 0.35 | 0.24 | 1.42 | 1.40 | 3.53 |
| Return on Equity (ROE) | -106.90% | -2,634.33% | -134.97% | -89.14% | -32.41% | |
| Return on Assets (ROA) | -25.70% | -64.28% | -71.63% | -47.18% | -33.76% | -9.83% |
| Return on Capital Employed (ROCE) | -39.20% | 177.90% | 675.70% | -117.70% | -87.00% | -12.80% |
| Earnings Yield | -84.71% | -193.64% | -262.32% | -51.49% | -29.57% | -4.94% |
| FCF Yield | -8.66% | -124.20% | -93.86% | -38.14% | -26.91% | -5.34% |
| Buyback Yield / Dilution | -213.01% | -107.81% | -43.08% | -39.12% | -12.57% | -61.08% |